The American Cancer Society Reverses Its Strong Position on Mammograms and PSA Testing

Dr. Otis Brawley, chief medical officer of the American Cancer Society told the New York Times on Wednesday, October 21, 2009, “We don’t want people to panic, but I’m admitting that American medicine has overpromised when it comes to screening. The advantages to screening have been exaggerated.”

Should I Be Tested for... H. Gilbert Welch M.D. ... Best Price: $4.28 Buy New $17.99 (as of 04:55 UTC - Details)

How does your personal physician communicate confidence and comfort to you now? “I am sorry I recommended a mammogram that resulted in an unnecessary amputation of your breast?” How consoling do these words feel, “It is a shame you haven’t had an erection in the past 10 years due to the PSA test I insisted you get, that led to debilitating prostate treatments – I hope you and your wife understand I was just following orders from the American Cancer Society?” Tens of millions of women and men have been irreparably damaged by the universal and enthusiastic recommendations for “early detection programs,” also known as “screening,” from their personal physicians, neighborhood breast and prostate clinics, community hospitals, national medical associations and medical societies over the past four decades. Now, all that the faithful patients get is a timid apology from the American Cancer Society, evoked by an article in the October 21, 2009 issue of Journal of the American Medical Association, titled “Rethinking Screening for Breast Cancer and Prostate Cancer.” Since, in my opinion, this admission of guilt is insufficient, what would be fair retribution for the harms done?

Adequate scientific evidence to stop mass screening programs has been readily available to your personal doctor for more than three decades. A flick of the “on” button of his or her computer, and a ten-minute search at the National Library of Medicine (www.pubmed.gov) would have revealed the truth. In 1976 Pietro M. Gullino presented his findings on the natural history of cancer, showing early detection is really late detection, at the Conference on Breast Cancer: A Report to the Profession, sponsored by the White House, the National Cancer Institute, and the American Cancer Society. He explained: “If the time required for a tumor to double its diameter during a known period of time is taken as a measure of growth rate, one can calculate by extrapolation that two-thirds of the duration of a breast cancer remains undetectable by the patient or physician. Long before a breast carcinoma can be detected by present technology, metastatic spread may occur and does in most cases.” This report was subsequently published in the journal representing the American Cancer Society (Cancer).

Anticancer: A New Way ... David Servan-Schreiber Best Price: $0.25 Buy New $2.84 (as of 10:47 UTC - Details)

In more familiar words, Dr. Gullino and many other researchers have clearly told everyone listening: mammography, breast self-examination, PSA and digital rectal exam are really late detection methods and cannot be expected to save lives by “catching cancer before it spreads.” Unfortunately, there is no profit in telling this truth. So, 386,560 people in the US are diagnosed annually with breast cancer (194,280) and prostate cancer (192,280); many of them through screening.

Cancer Mongering – the Most Successful of All Medical Enterprises

Cancer-screening businesses using two modern technologies – the mammogram and the blood test, prostate specific antigen (PSA) – have captured more customers than all other efforts combined. Campaigns have been so effective that about 75 percent of men have had a routine PSA test and about 70 percent of women older than 40 report they have had a recent mammogram. More than $20 billion is spent annually on screening for these two diseases.

The McDougall Program ... John A. McDougall Best Price: $2.05 Buy New $8.95 (as of 03:50 UTC - Details)

There are two customary ways a doctor-patient relationship is established. The traditional means is that you become ill and you seek out the advice of a doctor. In this case you initiate the relationship. The worth of the evidence supporting the doctor’s treatment does not need to be very solid. Your doctor is acting in his or her professional capacity to offer you the best available remedies without any real guarantee of the outcome. Remember, you asked for the help.

The second means of establishing a doctor-patient relationship became common with the introduction of programs looking for “early” cancer (screening). In this scenario the doctor comes looking for you. Life is good – you are enjoying your family, hobbies, and work. Then a knock sounds at your front door by way of a radio, TV, or magazine advertisement. Just as likely, during an office visit for an unrelated issue, such as a virus cold, your doctor admonishes you for failing to have your annual mammogram or PSA test. Through screening programs millions of people have become patients. When the doctor turns unsuspecting men and women into customers then the evidence that the outcome of this campaign will be far “more good than harm” must be unquestionable.

On October 21, 2009 the public was told by the American Cancer Society that this has not been the case for breast and prostate screening. Why now? The evidence has not changed – the only change is that now a few more people are willing to tell the truth. Why the delay? Annually, there is $20 billion at stake for screening alone and hundreds of billions more for the tests and treatments that follow. The ivory towers of your town’s cancer centers have been built from the blood of men and women subjected to harmful screening programs.

Read the rest of the article

November 2, 2009